Does β-Hexosaminidase Function Only as a Degranulation Indicator in Mast Cells? The Primary Role of β-Hexosaminidase in Mast Cell Granules
暂无分享,去创建一个
Sakuo Yamada | S. Yamada | N. Fukuishi | Nobuyuki Fukuishi | Shinya Murakami | Akane Ohno | Naoya Yamanaka | Nobuaki Matsui | Kenji Fukutsuji | Kouji Itoh | Masaaki Akagi | M. Akagi | N. Matsui | S. Murakami | K. Fukutsuji | A. Ohno | N. Yamanaka | K. Itoh
[1] Exogenous and endogenous glycolipid antigens activate NKT cells during microbial infections , 2005, Nature.
[2] Calman Prussin,et al. IgE, mast cells, basophils, and eosinophils. , 2003, The Journal of allergy and clinical immunology.
[3] Ping Wu,et al. Role for lysosomal enzyme β-hexosaminidase in the control of mycobacteria infection , 2008, Proceedings of the National Academy of Sciences.
[4] R. Paus,et al. IL-15 constrains mast cell–dependent antibacterial defenses by suppressing chymase activities , 2007, Nature Medicine.
[5] Y. Li,et al. Studies on the glycosidases in jack bean meal. II. Sepation of various glycosidases by isoelectric focusing. , 1968, The Journal of biological chemistry.
[6] H. Labischinski,et al. Chapter 2 Bacterial peptidoglycan: overview and evolving concepts , 1994 .
[7] R. Proia,et al. The beta-hexosaminidase deficiency disorders: development of a clinical paradigm in the mouse. , 1997, Annals of medicine.
[8] J. Drazen,et al. Evaluation of the Substrate Specificity of Human Mast Cell Tryptase βI and Demonstration of Its Importance in Bacterial Infections of the Lung* , 2001, The Journal of Biological Chemistry.
[9] Steven D. Douglas. Analytic review: disorders of phagocyte function. , 1970, Blood.
[10] K. Austen,et al. Enzymes of the mast cell granule. , 1980, The Journal of investigative dermatology.
[11] G. Berry,et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. , 2006, The New England journal of medicine.
[12] Y. Jigami,et al. Molecular pathologies of and enzyme replacement therapies for lysosomal diseases. , 2006, CNS & neurological disorders drug targets.
[13] T. Zuberbier,et al. Control of Pseudomonas aeruginosa skin infections in mice is mast cell-dependent. , 2007, The American journal of pathology.
[14] K. Tasaka,et al. Antiallergic effects of terfenadine on immediate type hypersensitivity reactions. , 1987, Immunopharmacology and immunotoxicology.
[15] L. Groebe,et al. The multiple mechanisms of Ca2+ signalling by listeriolysin O, the cholesterol‐dependent cytolysin of Listeria monocytogenes , 2007, Cellular microbiology.
[16] K. Takechi,et al. Plastid peptidoglycan. , 2010, Biochimica et biophysica acta.
[17] R. Schiffmann,et al. Enzyme Therapy in Type 1 Gaucher Disease: Comparative Efficacy of Mannose-Terminated Glucocerebrosidase from Natural and Recombinant Sources , 1995, Annals of Internal Medicine.
[18] P. Stock,et al. Recent advances in the role of NKT cells in allergic diseases and asthma , 2008, Current allergy and asthma reports.
[19] M. Olivier,et al. Aspergillus fumigatus induces immunoglobulin E-independent mast cell degranulation. , 2009, The Journal of infectious diseases.
[20] P. A. van der Merwe,et al. The mast cell tumor necrosis factor alpha response to FimH-expressing Escherichia coli is mediated by the glycosylphosphatidylinositol-anchored molecule CD48. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[21] C. Bachert,et al. Staphylococcus aureus enterotoxin B, protein A, and lipoteichoic acid stimulations in nasal polyps. , 2008, The Journal of allergy and clinical immunology.
[22] B. Zweiman,et al. The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis. , 1995, The Journal of clinical investigation.
[23] Gunnar Pejler,et al. Mast cell proteases: multifaceted regulators of inflammatory disease. , 2010, Blood.
[24] D. Mahuran,et al. Lending a helping hand, screening chemical libraries for compounds that enhance β‐hexosaminidase A activity in GM2 gangliosidosis cells , 2007, The FEBS journal.
[25] G. Caughey. Mast cell tryptases and chymases in inflammation and host defense , 2007, Immunological reviews.
[26] R. Stevens,et al. Protease–proteoglycan complexes of mouse and human mast cells and importance of their β‐tryptase–heparin complexes in inflammation and innate immunity , 2007, Immunological reviews.
[27] S. Bhakdi,et al. Mast cells determine the magnitude of bacterial toxin‐induced skin inflammation , 2009, Experimental dermatology.
[28] R. Dwek,et al. Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis , 2002, Neuropathology and applied neurobiology.
[29] D. Metcalfe,et al. Sounding the Alarm in Infection , 2004 .
[30] C. Janeway,et al. Evolution of the innate immune system , 2001 .
[31] R. Proia,et al. Physiological Substrates for Human Lysosomal β-Hexosaminidase S* , 2002, The Journal of Biological Chemistry.
[32] Gudrun Brandes,et al. Clostridium difficile Toxins A and B Directly Stimulate Human Mast Cells , 2007, Infection and Immunity.
[33] R. Proia,et al. Lysosomal Glycosphingolipid Recognition by NKT Cells , 2004, Science.
[34] S. Abraham,et al. Mast cell modulation of neutrophil influx and bacterial clearance at sites of infection through TNF-α , 1996, Nature.
[35] D. Umetsu,et al. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity , 2003, Nature Medicine.
[36] S. Kusumoto,et al. Mitogenic Effects of Bacterial Cell Walls, Their Fragments, and Related Synthetic Compounds on Thymocytes and Splenocytes of Guinea Pigs , 1979, Infection and immunity.
[37] H. Nakanishi,et al. Tryptase Inhibition Blocks Airway Inflammation in a Mouse Asthma Model1 , 2002, The Journal of Immunology.
[38] Michael P. McDonald,et al. Mouse models of Tay–Sachs and Sandhoff diseases differ in neurologic phenotype and ganglioside metabolism , 1995, Nature Genetics.
[39] P. A. Shore. [259] Fluorometric assay of histamine☆ , 1971 .
[40] D. Seldin,et al. Interleukin 3: A differentiation and growth factor for the mouse mast cell that contains chondroitin sulfate E proteoglycan. , 1984, Journal of immunology.
[41] M. Castells. Mast cell mediators in allergic inflammation and mastocytosis. , 2006, Immunology and allergy clinics of North America.
[42] D. Umetsu,et al. Natural killer T cells are important in the pathogenesis of asthma: the many pathways to asthma. , 2010, The Journal of allergy and clinical immunology.
[43] K.,et al. Tryptase from human pulmonary mast cells. Purification and characterization. , 1981, The Journal of biological chemistry.
[44] S. Abraham,et al. Mast cell-orchestrated immunity to pathogens , 2010, Nature Reviews Immunology.
[45] R. Djukanović,et al. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma. , 2001, The Journal of allergy and clinical immunology.
[46] T. Harada,et al. Antimicrobial effects of Burow’s solution on Staphylococcus aureus and Pseudomonas aeruginosa , 2012, Medical Molecular Morphology.
[47] M. Potier,et al. Purification and some properties of liver and brain β-N-Acetyl-hexosaminidase S , 1979 .
[48] N. Takemori,et al. Ultrastructural evidence for the origin of mast cells in normal human bone marrow , 1991, American journal of hematology.
[49] D. Tsuji,et al. Mechanism of abnormal growth in astrocytes derived from a mouse model of GM2 gangliosidosis , 2009, Journal of neurochemistry.
[50] D. Tsuji,et al. Production of Recombinant β-Hexosaminidase A, a Potential Enzyme for Replacement Therapy for Tay-Sachs and Sandhoff Diseases, in the Methylotrophic Yeast Ogataea minuta , 2007, Applied and Environmental Microbiology.
[51] F. Gunzer,et al. Selective Activation of Human Intestinal Mast Cells by Escherichia coli Hemolysin1 , 2008, The Journal of Immunology.
[52] D. Metcalfe,et al. IL-3-dependent murine mast cells undergo apoptosis on removal of IL-3. Prevention of apoptosis by c-kit ligand. , 1993, Journal of immunology.
[53] C. Tsai,et al. Purification and Characterization , 2006 .